Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natroba for Scabies
NCT02485717Phase 3Completed
- Sponsor
- ParaPRO
- Start
- May 2017
- Primary completion
- Jun 2018
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in scabies comparing Natroba with Placebo (2 arms). Primary endpoint: Number of Index Subjects Completely Cured of Scabies After a Single Treatment at 28 days. Started May 2017; status: completed.
02
Drugs
spinosad
03
Conditions
scabies
Beyond the preview
Go deeper on NCT02485717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485717.